Avoiding a Med-Wreck: a structured medication reconciliation framework and standardized auditing tool utilized to optimize patient safety and reallocate hospital resources

The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to reduce ADE in the hospital and community setting. Amid the coronavirus disease 2019 (COVID...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical policy and practice Vol. 14; no. 1; p. 10
Main Authors Elbeddini, Ali, Almasalkhi, Sarah, Prabaharan, Thulasika, Tran, Cindy, Gazarin, Mohamed, Elshahawi, Ahmed
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 19.01.2021
BioMed Central
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to reduce ADE in the hospital and community setting. Amid the coronavirus disease 2019 (COVID-19) pandemic, preventing medication errors is vital to avoid patient readmission, reduce disease complications, and reduce cost and patient burden on the healthcare system. To develop a standardized MedRec framework that can be implemented in all healthcare settings to reduce patient and staff harm during COVID-19. Also, to create a standardized auditing tool used to assess the quality of the MedRec process and allow for continuous quality improvement. A multi-site gap analysis (MGA) was performed to collect observational data that were collected from four different healthcare sites (two hospitals, a long-term care facility, and a community pharmacy). MGA consists of collecting data across several sites which answer a standardized questionnaire. A standardized MedRec framework and auditing tool were developed based on the gaps observed in each site and literature reviews. A standardized MedRec process was not implemented in any of the observed sites. The healthcare sites lacked a designated MedRec team and training related to the MedRec process leading to multiple discrepancies at discharge. Patients were not counselled on changes to home medications, and a discharge report was often not provided upon discharge. Communication mechanisms between community pharmacies and hospital physicians are not available or easily accessible. The proposed structured MedRec framework is vital to reduce medication errors and patient harm amid COVID-19. Moreover, the comprehensive auditing tool developed in this study allows for continuous quality improvement resulting in superior quality care, reduction of workflow inefficiencies, cost savings on hospital readmissions, and overall enhanced healthcare system performance.
AbstractList Background The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to reduce ADE in the hospital and community setting. Amid the coronavirus disease 2019 (COVID-19) pandemic, preventing medication errors is vital to avoid patient readmission, reduce disease complications, and reduce cost and patient burden on the healthcare system. Objectives To develop a standardized MedRec framework that can be implemented in all healthcare settings to reduce patient and staff harm during COVID-19. Also, to create a standardized auditing tool used to assess the quality of the MedRec process and allow for continuous quality improvement. Methods A multi-site gap analysis (MGA) was performed to collect observational data that were collected from four different healthcare sites (two hospitals, a long-term care facility, and a community pharmacy). MGA consists of collecting data across several sites which answer a standardized questionnaire. A standardized MedRec framework and auditing tool were developed based on the gaps observed in each site and literature reviews. Results A standardized MedRec process was not implemented in any of the observed sites. The healthcare sites lacked a designated MedRec team and training related to the MedRec process leading to multiple discrepancies at discharge. Patients were not counselled on changes to home medications, and a discharge report was often not provided upon discharge. Communication mechanisms between community pharmacies and hospital physicians are not available or easily accessible. Conclusion The proposed structured MedRec framework is vital to reduce medication errors and patient harm amid COVID-19. Moreover, the comprehensive auditing tool developed in this study allows for continuous quality improvement resulting in superior quality care, reduction of workflow inefficiencies, cost savings on hospital readmissions, and overall enhanced healthcare system performance.
Background The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to reduce ADE in the hospital and community setting. Amid the coronavirus disease 2019 (COVID-19) pandemic, preventing medication errors is vital to avoid patient readmission, reduce disease complications, and reduce cost and patient burden on the healthcare system. Objectives To develop a standardized MedRec framework that can be implemented in all healthcare settings to reduce patient and staff harm during COVID-19. Also, to create a standardized auditing tool used to assess the quality of the MedRec process and allow for continuous quality improvement. Methods A multi-site gap analysis (MGA) was performed to collect observational data that were collected from four different healthcare sites (two hospitals, a long-term care facility, and a community pharmacy). MGA consists of collecting data across several sites which answer a standardized questionnaire. A standardized MedRec framework and auditing tool were developed based on the gaps observed in each site and literature reviews. Results A standardized MedRec process was not implemented in any of the observed sites. The healthcare sites lacked a designated MedRec team and training related to the MedRec process leading to multiple discrepancies at discharge. Patients were not counselled on changes to home medications, and a discharge report was often not provided upon discharge. Communication mechanisms between community pharmacies and hospital physicians are not available or easily accessible. Conclusion The proposed structured MedRec framework is vital to reduce medication errors and patient harm amid COVID-19. Moreover, the comprehensive auditing tool developed in this study allows for continuous quality improvement resulting in superior quality care, reduction of workflow inefficiencies, cost savings on hospital readmissions, and overall enhanced healthcare system performance. Keywords: Medication reconciliation, Auditing tool, Medication errors, COVID-19, Cost-effective analysis
The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to reduce ADE in the hospital and community setting. Amid the coronavirus disease 2019 (COVID-19) pandemic, preventing medication errors is vital to avoid patient readmission, reduce disease complications, and reduce cost and patient burden on the healthcare system. To develop a standardized MedRec framework that can be implemented in all healthcare settings to reduce patient and staff harm during COVID-19. Also, to create a standardized auditing tool used to assess the quality of the MedRec process and allow for continuous quality improvement. A multi-site gap analysis (MGA) was performed to collect observational data that were collected from four different healthcare sites (two hospitals, a long-term care facility, and a community pharmacy). MGA consists of collecting data across several sites which answer a standardized questionnaire. A standardized MedRec framework and auditing tool were developed based on the gaps observed in each site and literature reviews. A standardized MedRec process was not implemented in any of the observed sites. The healthcare sites lacked a designated MedRec team and training related to the MedRec process leading to multiple discrepancies at discharge. Patients were not counselled on changes to home medications, and a discharge report was often not provided upon discharge. Communication mechanisms between community pharmacies and hospital physicians are not available or easily accessible. The proposed structured MedRec framework is vital to reduce medication errors and patient harm amid COVID-19. Moreover, the comprehensive auditing tool developed in this study allows for continuous quality improvement resulting in superior quality care, reduction of workflow inefficiencies, cost savings on hospital readmissions, and overall enhanced healthcare system performance.
The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to reduce ADE in the hospital and community setting. Amid the coronavirus disease 2019 (COVID-19) pandemic, preventing medication errors is vital to avoid patient readmission, reduce disease complications, and reduce cost and patient burden on the healthcare system. To develop a standardized MedRec framework that can be implemented in all healthcare settings to reduce patient and staff harm during COVID-19. Also, to create a standardized auditing tool used to assess the quality of the MedRec process and allow for continuous quality improvement. A multi-site gap analysis (MGA) was performed to collect observational data that were collected from four different healthcare sites (two hospitals, a long-term care facility, and a community pharmacy). MGA consists of collecting data across several sites which answer a standardized questionnaire. A standardized MedRec framework and auditing tool were developed based on the gaps observed in each site and literature reviews. A standardized MedRec process was not implemented in any of the observed sites. The healthcare sites lacked a designated MedRec team and training related to the MedRec process leading to multiple discrepancies at discharge. Patients were not counselled on changes to home medications, and a discharge report was often not provided upon discharge. Communication mechanisms between community pharmacies and hospital physicians are not available or easily accessible. The proposed structured MedRec framework is vital to reduce medication errors and patient harm amid COVID-19. Moreover, the comprehensive auditing tool developed in this study allows for continuous quality improvement resulting in superior quality care, reduction of workflow inefficiencies, cost savings on hospital readmissions, and overall enhanced healthcare system performance.
BACKGROUNDThe incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to reduce ADE in the hospital and community setting. Amid the coronavirus disease 2019 (COVID-19) pandemic, preventing medication errors is vital to avoid patient readmission, reduce disease complications, and reduce cost and patient burden on the healthcare system. OBJECTIVESTo develop a standardized MedRec framework that can be implemented in all healthcare settings to reduce patient and staff harm during COVID-19. Also, to create a standardized auditing tool used to assess the quality of the MedRec process and allow for continuous quality improvement. METHODSA multi-site gap analysis (MGA) was performed to collect observational data that were collected from four different healthcare sites (two hospitals, a long-term care facility, and a community pharmacy). MGA consists of collecting data across several sites which answer a standardized questionnaire. A standardized MedRec framework and auditing tool were developed based on the gaps observed in each site and literature reviews. RESULTSA standardized MedRec process was not implemented in any of the observed sites. The healthcare sites lacked a designated MedRec team and training related to the MedRec process leading to multiple discrepancies at discharge. Patients were not counselled on changes to home medications, and a discharge report was often not provided upon discharge. Communication mechanisms between community pharmacies and hospital physicians are not available or easily accessible. CONCLUSIONThe proposed structured MedRec framework is vital to reduce medication errors and patient harm amid COVID-19. Moreover, the comprehensive auditing tool developed in this study allows for continuous quality improvement resulting in superior quality care, reduction of workflow inefficiencies, cost savings on hospital readmissions, and overall enhanced healthcare system performance.
ArticleNumber 10
Audience Academic
Author Tran, Cindy
Almasalkhi, Sarah
Prabaharan, Thulasika
Elbeddini, Ali
Elshahawi, Ahmed
Gazarin, Mohamed
Author_xml – sequence: 1
  givenname: Ali
  orcidid: 0000-0002-3339-6203
  surname: Elbeddini
  fullname: Elbeddini, Ali
  email: elbeddini.a@gmail.com
  organization: Winchester District Memorial Hospital, 566 Louise Street, Winchester, ON, KK0C2K0, Canada. elbeddini.a@gmail.com
– sequence: 2
  givenname: Sarah
  surname: Almasalkhi
  fullname: Almasalkhi, Sarah
  organization: Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St, Toronto, M5S 3M2, Canada
– sequence: 3
  givenname: Thulasika
  surname: Prabaharan
  fullname: Prabaharan, Thulasika
  organization: Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St, Toronto, M5S 3M2, Canada
– sequence: 4
  givenname: Cindy
  surname: Tran
  fullname: Tran, Cindy
  organization: Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St, Toronto, M5S 3M2, Canada
– sequence: 5
  givenname: Mohamed
  surname: Gazarin
  fullname: Gazarin, Mohamed
  organization: Winchester District Memorial Hospital, 566 Louise Street, Winchester, ON, KK0C2K0, Canada
– sequence: 6
  givenname: Ahmed
  surname: Elshahawi
  fullname: Elshahawi, Ahmed
  organization: University of Toronto, Medical Sciences Building, Room 3157, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33468248$$D View this record in MEDLINE/PubMed
BookMark eNptkk1v1DAQhiNURMvSP8ABReLSS4q_ktgckFYVH5WKuIA4Wo492brNxovtdFX-En-S2U2puhKxlGTG8z722O_L4mgMIxTFa0rOKZXNuyRILeqKMFoRwlRTbZ8VJ4zUrOKM0qMn_8fFaUo3BB_VEk7Ji-KYc9FIJuRJ8Wd5F7zz46o05Vdw1c8I9vY9BinHyeYpgivX4Lw12YexxNkwWj_4OeyjWcM2xNvSjA4l-DbR-d8oMpPzecfNIQzllFGzS-dQhk32awzKDUJgzGUyPeT7PSKCGYaAi0F5HdLGZzNgLoUpWkiviue9GRKcPnwXxY9PH79ffKmuvn2-vFheVbbmda5q0dlOtW0jLVOuIaKnRjlgkrak77uOcAl1K7gVzAHteeOolQ46yjunqFN8UVzOXBfMjd5EvzbxXgfj9T4R4kqbmL0dQEvFGDBDhJRcCOBKNKIXDpSplWM1R9aHmbWZOjxHi_1GMxxAD2dGf61X4U63kgqG97Uozh4AMfyaIGW99snCMJgRwpQ0E60SVNVCYunbuXRlcGt-7AMS7a5cL5uaCI6Hsuvu_D9VOBysPd4u9B7zBwI2C2wMKUXoH3dPid55Uc9e1OhFvfei3qLozdO-HyX_nMf_An-n3_U
CitedBy_id crossref_primary_10_1007_s11096_024_01722_0
crossref_primary_10_1016_j_ajoc_2022_101658
crossref_primary_10_1186_s12913_022_08118_8
crossref_primary_10_1038_s41598_024_64605_4
Cites_doi 10.1177/1060028013507428
10.1001/archinte.165.4.424
10.1097/00001786-200504000-00001
10.1001/archinternmed.2011.215
10.1016/S2214-109X(20)30136-4
10.1007/s11096-009-9318-86
10.1111/j.1525-1497.2005.30390.x
10.1503/cmaj.1040498
10.1136/bmjopen-2015-010003
10.7326/0003-4819-138-3-200302040-00007
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: The Author(s) 2021
DBID NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1186/s40545-021-00296-w
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList

PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2052-3211
EndPage 10
ExternalDocumentID oai_doaj_org_article_8922e2a0488344e39464f4de9a59d253
A650439779
10_1186_s40545_021_00296_w
33468248
Genre Journal Article
GeographicLocations Ontario
GeographicLocations_xml – name: Ontario
GroupedDBID -A0
0R~
3V.
4.4
5VS
7RV
7X7
8AO
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABUWG
ACGFS
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AFKRA
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
AQUVI
ASPBG
AVWKF
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BKEYQ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
DIK
EBS
FRJ
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
ITC
KQ8
M0T
M48
M4Z
M~E
NAPCQ
NPM
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RBZ
ROL
RPM
RSV
SOJ
TDBHL
UKHRP
AAYXX
CITATION
7X8
5PM
AFPKN
ID FETCH-LOGICAL-c535t-54bcb97768c29d604f1a9de28170ffbb038e5743c42de1f36d1c8deb13bd91d93
IEDL.DBID RPM
ISSN 2052-3211
IngestDate Tue Dec 17 15:14:54 EST 2024
Tue Sep 17 20:50:38 EDT 2024
Fri Oct 25 07:18:51 EDT 2024
Tue Nov 19 21:19:09 EST 2024
Tue Nov 12 22:32:44 EST 2024
Thu Nov 21 21:59:37 EST 2024
Wed Oct 16 00:44:50 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
Cost-effective analysis
Auditing tool
Medication errors
Medication reconciliation
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c535t-54bcb97768c29d604f1a9de28170ffbb038e5743c42de1f36d1c8deb13bd91d93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-3339-6203
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814270/
PMID 33468248
PQID 2479419548
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_8922e2a0488344e39464f4de9a59d253
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7814270
proquest_miscellaneous_2479419548
gale_infotracmisc_A650439779
gale_infotracacademiconefile_A650439779
crossref_primary_10_1186_s40545_021_00296_w
pubmed_primary_33468248
PublicationCentury 2000
PublicationDate 2021-01-19
PublicationDateYYYYMMDD 2021-01-19
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-19
  day: 19
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of pharmaceutical policy and practice
PublicationTitleAlternate J Pharm Policy Pract
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
Taylor & Francis Group
Publisher_xml – sequence: 0
  name: Taylor & Francis Group
– name: BioMed Central Ltd
– name: BioMed Central
References PL Cornish (296_CR5) 2005; 1265
AB Mekonnen (296_CR9) 2016; 6
M Place (296_CR6) 2007
GR Baker (296_CR2) 2004; 170
S Scahill (296_CR13) 2009; 31
O Collaboration (296_CR14) 2020; 8
296_CR1
AJ Forster (296_CR11) 2005; 20
MS Buckley (296_CR12) 2013; 47
A Terry (296_CR3) 2005
296_CR8
296_CR16
AJ Forster (296_CR7) 2003; 138
H Hamilton (296_CR10) 2011; 171
M Najafzadeh (296_CR15) 2016; 22
T Vira (296_CR4) 2006; 0001
C Sullivan (296_CR17) 2005; 20
References_xml – ident: 296_CR16
– volume: 0001
  start-page: 1
  year: 2006
  ident: 296_CR4
  publication-title: Qual Saf Healthcare
  contributor:
    fullname: T Vira
– volume: 47
  start-page: 1599
  issue: 12
  year: 2013
  ident: 296_CR12
  publication-title: Ann Pharmacother
  doi: 10.1177/1060028013507428
  contributor:
    fullname: MS Buckley
– volume: 22
  start-page: 654
  issue: 10
  year: 2016
  ident: 296_CR15
  publication-title: Am J Manag Care
  contributor:
    fullname: M Najafzadeh
– ident: 296_CR8
– volume: 1265
  start-page: 424
  year: 2005
  ident: 296_CR5
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.165.4.424
  contributor:
    fullname: PL Cornish
– volume: 20
  start-page: 95
  issue: 2
  year: 2005
  ident: 296_CR17
  publication-title: J Nurse Care Qual
  doi: 10.1097/00001786-200504000-00001
  contributor:
    fullname: C Sullivan
– volume: 171
  start-page: 1013
  issue: 11
  year: 2011
  ident: 296_CR10
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2011.215
  contributor:
    fullname: H Hamilton
– volume: 8
  start-page: e754
  issue: 6
  year: 2020
  ident: 296_CR14
  publication-title: Lancet Global Health
  doi: 10.1016/S2214-109X(20)30136-4
  contributor:
    fullname: O Collaboration
– volume: 31
  start-page: 517
  year: 2009
  ident: 296_CR13
  publication-title: Pharm World Sci
  doi: 10.1007/s11096-009-9318-86
  contributor:
    fullname: S Scahill
– volume: 20
  start-page: 317
  issue: 4
  year: 2005
  ident: 296_CR11
  publication-title: J Gen Intern Med
  doi: 10.1111/j.1525-1497.2005.30390.x
  contributor:
    fullname: AJ Forster
– volume: 170
  start-page: 1678
  issue: 11
  year: 2004
  ident: 296_CR2
  publication-title: Can Med Assoc J
  doi: 10.1503/cmaj.1040498
  contributor:
    fullname: GR Baker
– volume: 6
  start-page: e010003
  issue: 2
  year: 2016
  ident: 296_CR9
  publication-title: BMJ open
  doi: 10.1136/bmjopen-2015-010003
  contributor:
    fullname: AB Mekonnen
– ident: 296_CR1
– volume: 138
  start-page: 161
  issue: 3
  year: 2003
  ident: 296_CR7
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-138-3-200302040-00007
  contributor:
    fullname: AJ Forster
– volume-title: A safer place for patients: learning to improve patient safety
  year: 2005
  ident: 296_CR3
  contributor:
    fullname: A Terry
– volume-title: Technical patient safety solutions for medicines reconciliation on admission of adults to hospital
  year: 2007
  ident: 296_CR6
  contributor:
    fullname: M Place
SSID ssj0000970310
Score 2.2430446
Snippet The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation...
Background The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication...
BACKGROUNDThe incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 10
SubjectTerms auditing tool
Care and treatment
Complications and side effects
Coronaviruses
cost-effective analysis
covid-19
Drugs
Epidemics
Long-term care of the sick
Medical care
Medical care, Cost of
Medication errors
medication reconciliation
Ontario
Patients
Pharmacy
Prevention
Quality management
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQbxYKMhIqBxo1cRwn5rYgqgqpqIdW9Gb5qa7YJoikVMtf4k8yYyftRhy4cIydOLbnG89M4vlMyJvc595WImRaM59xIxyoVM0zZN60TFstOWYjH38RR2f883l1vnXUF-4JS_TAaeIOGsmYZxqBVnLuS8kFD9x5qSvpWJV4PnO2FUzFNVgiL3s-Zck04qAHz4RjMjJEzzmTIrueWaJI2P_3srxll-Z7JreM0OF9cm_0Huky9foBuePbh2TvJNFPb_bp6W02Vb9P9-jJLTH15hH5vfzZrdBWUU2Pvcu-wmr37T1cJBLZqx_e0fivPUqLxljZrtZJeDRM27iobh2dPkGsfsFDGlM7sN2h69YU3r6OxUNHO1iRLuGCjvyttNfBD5vYBLirazSlg6cX4-klUJb-JvSPydnhp9OPR9l4WENmq7Iasooba8CZFI1l0omch0JL5xkSAIZgTF42vgJ3xXLmfBFK4QrbOLAUpXGycLJ8QnbarvXPCG1C4YIwYF49eHN10HVlwdF0pmHcQDC_IO8mwanviZNDxVimESqJWYGYVRSzul6QDyjbmzuRTzsWAMrUiDL1L5QtyFtEhkKtB_FbPSYvQIeRP0stBTLBwfDlguzO7gRttbPq1xO2FFbhFrfWd1e9Ysj1H_n3FuRpwtpNn8uSCxg81NQzFM4GNa9pVxeRLBwpzVidP_8fs_CC3GVRgYqskLtkB8DpX4JPNphXUf3-ANs8N88
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKuXBBvFkoyEioHGggsR1vjITQgqgqpEU9tKI3y_GjXbEksEkpy1_iTzLjJG0jeuAY23HizDv2fEPI89Sn3uYyJMYwn4hSOhCpqUgQedMyY40SmI08_yz3DsWno_xogwzljvoP2FwZ2mE9qcPV8tWvH-t3IPBvo8AX8nUDTofAPGMIjFOmZHJ2jVxnYBnxiNe8d_ejZlaI1o6_XVias4RD8DPk0Vw5zchWRUj_fxX3Jcs1PlV5yUzt3iI3e_-SzjqGuE02fHWHbO93ANXrHXpwkW_V7NBtun8BXb2-S_7MftYLtGbU0Ll3yRfQh1_fwEUHM3u68o7G3fhITxqjabtYduSlYTjoRU3l6PCTYvEbbjKY_IHztnW9pPD0ZWxua1qDzvoGF7RHeKWNCb5dxynAoV2isW09Penrm0Bbt9_Q3COHux8PPuwlfTmHxOY8b5NclLYEd1MWliknUxEyo5xnCBEYQlmmvPA5ODRWMOezwKXLbOHAlvDSqcwpfp9sVnXlHxJahMwFWYIB9uDvTYOZ5hZcUVcWTJQQ7k_Iy4Fw-nuH2qFjtFNI3ZFZA5l1JLM-m5D3SNvzkYi4HRvq1bHuBVgXijHPDCo8LoTnSkgRhPPK5MqxnE_IC-QMjZwK5LemT2-AF0aELT2TiBUHy1cTsjUaCfJsR93PBt7S2IWH4CpfnzaaYTWAiNA3IQ86Xjt_Z86FhMVDz3TEhaNFjXuqxUmEE0fQMzZNH_3Hcx-TGyzKR5ZkaotsAu_5J-CUteXTKGl_AQMJN-k
  priority: 102
  providerName: Scholars Portal
Title Avoiding a Med-Wreck: a structured medication reconciliation framework and standardized auditing tool utilized to optimize patient safety and reallocate hospital resources
URI https://www.ncbi.nlm.nih.gov/pubmed/33468248
https://search.proquest.com/docview/2479419548
https://pubmed.ncbi.nlm.nih.gov/PMC7814270
https://doaj.org/article/8922e2a0488344e39464f4de9a59d253
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZtB6MvY_d564IGo3tY3diyLFt7S0tLGaSE0bK8Cd28miV2adyV7C_tT-5IttuYve0lYMl2ZL5ztc_5hNDHyEZWp6wIpSQ2pIoZUKmMho55UxOpJaeuG3l6zs4u6dd5Ot9Cad8L44v2tSoPq8XysCqvfG3l9VKP-zqx8Wx67GiaSBaNt9E2uN-NFN2bX-4o2aO-QSZn4xUEJdT1IUPiHBHOwrtd9DhJKMuJ2_Znwx952v5_jfOGdxpWTm64otOn6EkXQ-JJu9ZnaMtWz9H-rCWhXh_gi4eeqtUB3sezB3rq9Qv0Z_KrLp3HwhJPrQm_g837-QUOWirZ2xtrsP_i7jHDPmPW5aKFEBd9MReWlcH9i4jyN1wkXYOHu29T1wsM_77ww02Na7BLSzjAHYsrXsnCNmt_CwhaF86hNhZfdXuYwFj7TWH1El2enlwcn4Xdlg2hTpO0CVOqtIKQkuWacMMiWsSSG0scDWBRKBUluU0haNGUGBsXCTOxzg34i0QZHhuevEI7VV3ZNwjnRWwKpsDJWojpskJmqYZw0yhATUFKH6DPPXDiumXmED6jyZloEReAuPCIi7sAHTls7890rNp-oL75ITrZEjknxBLpjFpCqU04ZbSgxnKZckPSJECfnGQIp_sAv5ZdCwMs2LFoiQlzfHDw-DxAe4MzQWf1YPpDL1vCTblCt8rWtytBHOO_Z-EL0OtW1u7X3ItsgLKBFA4eajgDGuQpwzuNefvfV75Du8QrUBzGfA_tgETa9xCONWoESjjPRujR0cn57NvIv9SA3ynNR14x_wJfZz3h
link.rule.ids 230,314,727,780,784,864,885,2102,2221,24318,27924,27925,31720,33745,53791,53793
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGkGAvE9cRGGAkNB5Y1sRxnJi3MjEVWKc-dGJvlm9hFW0yrdmm8pf4kxw7ydaINx5j5-LoO9fknM8IvY9sZHXKilBKYkOqmAGVymjomDc1kVpy6rqRxydsdEq_naVnGyjtemF80b5Ws4NyvjgoZ-e-tvJioQddndhgMj50NE0kiwb30P00yXi8lqR7A8wdKXvUtcjkbLCEsIS6TmRInSPCWXizhR4kCWU5cRv_rHkkT9z_r3le80_92sk1Z3T0CG23USQeNqt9jDZs-QTtTRoa6tU-nt51VS338R6e3BFUr56iP8PrauZ8FpZ4bE34A6zer09w0JDJXl1ag_0_d48a9jmzns0bEHHRlXNhWRrcfYqY_YaLpGvxcPetq2qO4elzP1xXuALLtIAD3PK44qUsbL3yt4Cwde5cam3xebuLCYw1fxWWz9Dp0Zfp4ShsN20IdZqkdZhSpRUElSzXhBsW0SKW3FjiiACLQqkoyW0KYYumxNi4SJiJdW7AYyTK8Njw5DnaLKvSvkA4L2JTMAVu1kJUlxUySzUEnEYBagqS-gB97IATFw03h_A5Tc5Eg7gAxIVHXNwE6LPD9vZMx6vtB6rLn6KVLpFzQiyRzqwllNqEU0YLaiyXKTckTQL0wUmGcNoP8GvZNjHAgh2PlhgyxwgHr88DtNs7E7RW96bfdbIl3JQrdSttdbUUxHH-ex6-AO00sna75k5kA5T1pLD3Uv0Z0CFPGt7qzMv_vvItejiajo_F8deT76_QFvHKFIcx30WbIJ32NQRntXrjVfEv4T085g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSNNeEHcCA4yExgPLmjiOG_NWBtW4dOrDJvZm-coq2qRaM6byl_iTHDvJ1og3HmPn4ug71-Sczwi9SWxidc5cLCWxMVXMgEoNaeyZNzWRWnLqu5Enx-zolH45y882tvoKRftazQ7K-eKgnJ2H2srlQg-6OrHBdHLoaZrIMBksjRvcRnfyDIRsI1EPRph7Yvaka5Mp2GAFoQn13ciQPieEs_hqB21nGWUF8Zv_bHilQN7_r4ne8FH9-skNhzS-h-62kSQeNSu-j27Z8gHamzZU1Ot9fHLTWbXax3t4ekNSvX6I_ox-VTPvt7DEE2vi72D5fr6Hg4ZQ9vLCGhz-uwfkcMib9WzeAIldV9KFZWlw9zli9hsukr7Nw9-3rqo5hqfPw3Bd4Qqs0wIOcMvlilfS2XodbgGh69y71dri83YnExhr_iysHqHT8aeTw6O43bgh1nmW13FOlVYQWLJCE25YQl0qubHEkwE6p1SSFTaH0EVTYmzqMmZSXRjwGpkyPDU8e4y2yqq0TxEuXGocU-BqLUR2QyeHuYag0yhATUFiH6F3HXBi2fBziJDXFEw0iAtAXATExVWEPnhsr8_03NphoLr4IVoJEwUnxBLpTVtGqc04ZdRRY7nMuSF5FqG3XjKEtwAAv5ZtIwMs2HNpiRHzrHDw-jxCu70zQXN1b_p1J1vCT_lyt9JWlytBPO9_4OKL0JNG1q7X3IlshIY9Key9VH8G9CgQh7d68-y_r3yFtqcfx-Lb5-Ovz9EOCbqUxinfRVsgnPYFxGe1ehk08S9Gyj35
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Avoiding+a+Med-Wreck%3A+a+structured+medication+reconciliation+framework+and+standardized+auditing+tool+utilized+to+optimize+patient+safety+and+reallocate+hospital+resources&rft.jtitle=Journal+of+pharmaceutical+policy+and+practice&rft.au=Elbeddini%2C+Ali&rft.au=Almasalkhi%2C+Sarah&rft.au=Prabaharan%2C+Thulasika&rft.au=Tran%2C+Cindy&rft.date=2021-01-19&rft.issn=2052-3211&rft.eissn=2052-3211&rft.volume=14&rft.issue=1&rft.spage=10&rft.epage=10&rft_id=info:doi/10.1186%2Fs40545-021-00296-w&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2052-3211&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2052-3211&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2052-3211&client=summon